{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:53:13Z","timestamp":1758124393726,"version":"3.37.3"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["213837","223273","217776"],"award-info":[{"award-number":["213837","223273","217776"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the South-East Norway Regional Health Authority","award":["2013\u2013123"],"award-info":[{"award-number":["2013\u2013123"]}]},{"name":"KG Jebsen Foundation","award":["SKGJ-2011-36"],"award-info":[{"award-number":["SKGJ-2011-36"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.schres.2015.10.021","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T23:30:41Z","timestamp":1445902241000},"page":"386-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serum level of venlafaxine is associated with better memory in psychotic disorders"],"prefix":"10.1016","volume":"169","author":[{"given":"Nils Eiel","family":"Steen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Aas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Dieset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Tesli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0468-4230","authenticated-orcid":false,"given":"Mari","family":"Nerhus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erlend","family":"Gardsjord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragni","family":"M\u00f8rch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Agartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Melle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Vaskinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2000","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","key":"10.1016\/j.schres.2015.10.021_bb0005"},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psychres.2014.05.013","article-title":"Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression\u2013a systematic review","volume":"219","author":"Baune","year":"2014","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","article-title":"The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes","volume":"42","author":"Berridge","year":"2003","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.schres.2015.10.021_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/acps.12133","article-title":"Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis","volume":"128","author":"Bourne","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.10.021_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2006.10.028","article-title":"Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression","volume":"101","author":"Bremner","year":"2007","journal-title":"J. Affect. Disord."},{"issue":"7","key":"10.1016\/j.schres.2015.10.021_bb0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/bdd.562","article-title":"Pharmacokinetic modelling of blood\u2013brain barrier transport of escitalopram in rats","volume":"28","author":"Bundgaard","year":"2007","journal-title":"Biopharm. Drug Dispos."},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bdi.12234","article-title":"Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study","volume":"17","author":"Carlborg","year":"2015","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.schres.2015.10.021_bb0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijpsycho.2012.04.001","article-title":"Systolic blood pressure reactions to acute stress are associated with future hypertension status in the Dutch famine birth cohort study","volume":"85","author":"Carroll","year":"2012","journal-title":"Int. J. Psychophysiol."},{"issue":"5","key":"10.1016\/j.schres.2015.10.021_bb0045","first-page":"28","article-title":"Current management of schizophrenia: antipsychotic monotherapy versus combination therapy","volume":"5","author":"Cascade","year":"2008","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.schres.2015.10.021_bb0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0079-6123(07)00020-9","article-title":"What are the differences between long-term, short-term, and working memory?","volume":"169","author":"Cowan","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"7","key":"10.1016\/j.schres.2015.10.021_bb0055","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0269881113482531","article-title":"The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression","volume":"27","author":"Cowen","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2015.10.021_bb0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/026988110201600305","article-title":"Memory performance in panic disorder patients after chronic use of clomipramine","volume":"16","author":"de Carvalho","year":"2002","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1461145705006413","article-title":"Differential physiological effects of a low dose and high doses of venlafaxine in major depression","volume":"10","author":"Debonnel","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"year":"2005","series-title":"The Delis\u2013Kaplan Executive Function System: D-KEFS","author":"Delis","key":"10.1016\/j.schres.2015.10.021_bb0070"},{"year":"2004","series-title":"California Verbal Learning Test: CVLT-II","author":"Delis","key":"10.1016\/j.schres.2015.10.021_bb0075"},{"issue":"12","key":"10.1016\/j.schres.2015.10.021_bb0080","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.biopsych.2006.03.082","article-title":"Hippocampal neurogenesis: regulation by stress and antidepressants","volume":"59","author":"Dranovsky","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.10.021_bb0085","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/15374410903297148","article-title":"An exploratory analysis of the impact of family functioning on treatment for depression in adolescents","volume":"38","author":"Feeny","year":"2009","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.schres.2015.10.021_bb0090","series-title":"Biometrics Research","article-title":"Structured Clinical Interview for DSM-IV Axis I Disorders: Patient Edition (SCID-P), Version 2","author":"First","year":"1995"},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/FTD.0000000000000101","article-title":"Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline","volume":"37","author":"Gjestad","year":"2015","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00213-005-0274-2","article-title":"Cognitive performance in depressed patients after chronic use of antidepressants","volume":"185","author":"Gorenstein","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.schres.2015.10.021_bb0105","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1089\/neu.2010.1563","article-title":"Imipramine treatment improves cognitive outcome associated with enhanced hippocampal neurogenesis after traumatic brain injury in mice","volume":"28","author":"Han","year":"2011","journal-title":"J. Neurotrauma"},{"year":"2004","series-title":"Statistical Analysis and Data Display: An Intermediate Course with Examples in S-plus, R, and SAS","author":"Heiberger","key":"10.1016\/j.schres.2015.10.021_bb0110"},{"issue":"9","key":"10.1016\/j.schres.2015.10.021_bb0115","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpsychires.2008.10.015","article-title":"Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder","volume":"43","author":"Herrera-Guzman","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.schres.2015.10.021_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"10.1016\/j.schres.2015.10.021_bb0125","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1176\/appi.ajp.2007.05111903","article-title":"Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia","volume":"164","author":"Ho","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.10.021_bb0130","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4088\/JCP.08m04837yel","article-title":"Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder","volume":"71","author":"Jabben","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.10.021_bb0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1521\/suli.2007.37.2.165","article-title":"Suicide acceptability is related to suicide planning in U.S. adolescents and young adults","volume":"37","author":"Joe","year":"2007","journal-title":"Suicide Life Threat. Behav."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.10.021_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.schres.2008.12.002","article-title":"Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial","volume":"108","author":"Joffe","year":"2009","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0447.2012.01911.x","article-title":"Predictors of medication adherence in patients with schizophrenia and bipolar disorder","volume":"127","author":"Jonsdottir","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"issue":"10","key":"10.1016\/j.schres.2015.10.021_bb0150","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","article-title":"Schizophrenia is a cognitive illness: time for a change in focus","volume":"70","author":"Kahn","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2015.10.021_bb0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/7854_2010_42","article-title":"Neurocognition in schizophrenia","volume":"4","author":"Kalkstein","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.schres.2015.10.021_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","article-title":"A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder","volume":"27","author":"Katona","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2015.10.021_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"8","key":"10.1016\/j.schres.2015.10.021_bb0170","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4088\/JCP.13r08609","article-title":"Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review","volume":"75","author":"Keefe","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2015.10.021_bb0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jad.2014.06.032","article-title":"Neuropsychological performance in melancholic, atypical and undifferentiated major depression during depressed and remitted states: a prospective longitudinal study","volume":"168","author":"Lin","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2015.10.021_bb0180","first-page":"701","article-title":"Augmentation with antidepressants in schizophrenia treatment: benefit or risk","volume":"11","author":"Mao","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.comppsych.2006.03.008","article-title":"Generalizability studies of the global assessment of functioning-split version","volume":"48","author":"Pedersen","year":"2007","journal-title":"Compr. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2015.10.021_bb0190","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1176\/appi.ajp.160.8.1516","article-title":"Untreated depression and hippocampal volume loss","volume":"160","author":"Sheline","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.10.021_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/schbul\/sbp034","article-title":"Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group","volume":"37","author":"Simonsen","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2015.10.021_bb0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1076\/1385-4046(200008)14:3;1-P;FT295","article-title":"Differential impact of executive dysfunction on verbal list learning and story recall","volume":"14","author":"Tremont","year":"2000","journal-title":"Clin. Neuropsychol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.10.021_bb0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.schres.2014.08.015","article-title":"Antidepressants for cognitive impairment in schizophrenia \u2014 a systematic review and meta-analysis","volume":"159","author":"Vernon","year":"2014","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2015.10.021_bb0210","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.euroneuro.2015.04.014","article-title":"Cognitive enhancing agents in schizophrenia and bipolar disorder","volume":"25","author":"Vreeker","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2015.10.021_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2004.04.002","article-title":"Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment","volume":"56","author":"Vythilingam","year":"2004","journal-title":"Biol. Psychiatry"},{"year":"2008","series-title":"Wechsler Memory Scale: WMS-III","author":"Wechsler","key":"10.1016\/j.schres.2015.10.021_bb0220"},{"year":"2003","series-title":"Wechsler Adult Intelligence Scale: WAIS-III","author":"Wechsler","key":"10.1016\/j.schres.2015.10.021_bb0225"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415300219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415300219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T01:08:47Z","timestamp":1569373727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415300219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":45,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0920996415300219"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.10.021","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum level of venlafaxine is associated with better memory in psychotic disorders","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}